Stroke Thrombolytics: Don’t Skip Hemorrhage Risk Assessment!
- Eric Steinberg

- May 4
- 2 min read
Clinical Scenario
A 68-year-old man presents with right-sided weakness and slurred speech (NIHSS 12), with a negative CT, making him a clear thrombolytic candidate. As you review the risks and benefits, she seems to be on board, but asks, “What’s his chance of bleeding? Do you think it’s worth it?” You step out briefly, pull up MDCalc to better individualize the risk.
Check out the HAT and SEDAN scores on MDCalc to quickly assess post-tPA hemorrhage risk at the bedside.
Summary
HAT: Quick, simple estimate of hemorrhage risk using readily available clinical + basic CT findings.
SEDAN: More granular, imaging-informed risk estimate, incorporating additional CT features.
Tool Comparison
Purpose | Predict risk of symptomatic intracranial hemorrhage (sICH) after tPA. | Predict sICH after tPA with added imaging detail. |
Use When... | You want a fast, practical estimate using core clinical + basic CT data. | You want a more precise risk estimate using additional CT findings. |
Scoring | Uses NIHSS, glucose, easily visible hypodensity on CT. | Uses blood glucose, NIHSS, age, early infarct signs, and hyperdense artery sign on CT. |
Performance | Performs well for a quick estimate, but less robust overall. | Strong overall performance, driven by additional imaging inputs. |
Workup | Uses readily available early clinical, lab, and basic CT data. | Requires more detailed imaging plus clinical and lab data. |
Common Pitfalls |
|
|
Case Resolution
You review his hemorrhage risk using HAT and, given detailed CT findings are available, apply SEDAN for a more refined estimate. After a brief discussion, she agrees to proceed, and thrombolytics are administered without delay.

